Hoese & Co’s GSK GSK Stock Holding History

Hoese & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-160	Closed	-$5.8K	–	152
2023 Q3	$5.8K	Hold	160	–	–	0.01%	138
2023 Q2	$5.7K	Hold	160	–	–	0.01%	152
2023 Q1	$5.48K	Hold	160	–	–	0.01%	150
2022 Q4	$6K	Hold	160	–	–	0.01%	149
2022 Q3	$5K	Hold	160	–	–	0.01%	161
2022 Q2	$9K	Hold	160	–	–	0.01%	146
2022 Q1	$9K	Hold	160	–	–	0.01%	156
2021 Q4	$9K	Hold	160	–	–	0.01%	150
2021 Q3	$8K	Hold	160	–	–	0.01%	142
2021 Q2	$8K	Buy	+160	New	+$7.69K	0.01%	146

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hoese & Co's GSK Position: Q4 2023 in Review

Hoese & Co sold out of GSK (GSK) in Q4 2023, closing a stake of 160 shares — an estimated $5.8K sold.

Hoese & Co first reported a position in GSK in Q2 2021 and held it in 10 quarters. The position peaked at $9K in Q2 2022. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

Hoese & Co reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
Hoese & Co sold 160 GSK shares in Q4 2023, an estimated $5.8K.
Hoese & Co first reported a position in GSK in Q2 2021 and held it in 10 quarters.
Hoese & Co's GSK position peaked at $9K in Q2 2022.
895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Hoese & Co's 13F filing for Q4 2023, filed 4 Jan 2024.